Cart
sales@molnova.com
ISOBUTYRALDEHYDE OXIME
CAS No. 151-00-8
ISOBUTYRALDEHYDE OXIME( —— )
Catalog No. M19919 CAS No. 151-00-8
2-methylpropanal oxime is an aldoxime derived from 2-methylpropanal. It derives from an isobutyraldehyde.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 10MG | 68 | In Stock |
|
| 25MG | 115 | In Stock |
|
| 50MG | 173 | In Stock |
|
| 100MG | 258 | In Stock |
|
| 200MG | 388 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameISOBUTYRALDEHYDE OXIME
-
NoteResearch use only, not for human use.
-
Brief Description2-methylpropanal oxime is an aldoxime derived from 2-methylpropanal. It derives from an isobutyraldehyde.
-
Description2-methylpropanal oxime is an aldoxime derived from 2-methylpropanal. It derives from an isobutyraldehyde.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number151-00-8
-
Formula Weight87.12
-
Molecular FormulaC4H9NO
-
Purity>98% (HPLC)
-
SolubilityDMSO:10 mM
-
SMILESCC(C)C=NO
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Etelcalcetide
Etelcalcetide (AMG 416) is a synthetic peptide as an activator of the calcium sensing receptor (CaSR). Etelcalcetide is a calcimimetic drug for the treatment of secondary hyperparathyroidism in patients undergoing hemodialysis.
-
CPI-1189
REN-1189 is a TNF-a release inhibitor potentially for the treatment of sciatica and postherpetic neuralgia.
-
IGF-I Analog
JB-1, an IGF-1 peptide analog, is a selective and potent IGF-1R antagonist. JB-1 competes with IGF-1 by binding the IGF-1 receptor. JB-1 prevents the autophosphorylation of IGF-1R, and has no activity in IGF-II.
